US20050182339A1 - Excisional biopsy devices and methods - Google Patents

Abstract

An excisional biopsy system includes a tubular member that has a proximal end and a distal end in which one or more windows are defined. A first removable probe has a proximal portion that includes a cutting tool extender and a distal portion that includes a cutting tool. The first removable probe may be configured to fit at least partially within the tubular member to enable the cutting tool to selectively bow out of and to retract within one of the windows when the cutting tool extender is activated. A second removable probe has a proximal section that includes a tissue collection device extender and a distal section that includes a tissue collection device. The second removable probe may also be configured to fit at least partially within the tubular member to enable the tissue collection device to extend out of and to retract within one of the windows when the tissue collection device extender is activated. A third removable probe may also be provided. The third removable probe may also be configured to fit at least partially within the tubular member and may include an imaging device, such as an ultrasound transducer, mounted therein. By selectively activating the cutting tool and the tissue collection device while rotating the excisional device, a tissue specimen may be cut from the surrounding tissue and collected for later analysis.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
• The present application is a continuation-in-part of U.S. patent application Ser. No. 09/417,520, which is a divisional patent application of U.S. patent application Ser. No. 09/146,743, now U.S. Pat. No. 6,022,362.
BACKGROUND OF THE INVENTION
• 1. Field of the Invention
• The present invention pertains to the field of soft tissue excisional biopsy devices and methods. In particular, the present invention relates to the field of devices and methods for excising suspicious lesions from soft tissue, such as breast tissue.
• 2. Description of the Related Art
• Breast cancer is a major threat and concern to women. Early detection and treatment of suspicious or cancerous lesions in the breast has been shown to improve long-term survival of the patient. The trend is, therefore, to encourage women not only to perform monthly self-breast examination and obtain a yearly breast examination by a qualified physician, but also to undergo annual screening mammography commencing at age 40. Mammography is the only screening modality available today that can detect small, nonpalpable lesions. These nonpalpable lesions may appear as opaque densities relative to normal breast parenchyma and fat or as clusters of microcalcifications.
• The conventional method for diagnosing, localizing and excising nonpalpable lesions detected by mammography generally involves a time-consuming, multi-step process. First, the patient goes to the radiology department where the radiologist finds and localizes the lesion either using mammography or ultrasound guidance. Once localized, a radio-opaque wire is inserted into the breast. The distal end of the wire may include a small hook or loop. Ideally, this is placed adjacent to the suspicious area to be biopsied. The patient is then transported to the operating room. Under general or local anesthesia, the surgeon performs a procedure called a needle-localized breast biopsy. In the needle-localized breast biopsy, the surgeon, guided by the wire previously placed in the patient's breast, excises a mass of tissue around the distal end of the wire. The specimen is sent to the radiology department where a specimen radiograph is taken to confirm that the suspicious lesion is contained within the excised specimen. Meanwhile, the surgeon, patient, anesthesiologist and operating room staff, wait in the operating room for confirmation of that fact from the radiologist before the operation is completed. The suspicious lesion should ideally be excised in toto with a small margin or rim of normal breast tissue on all sides. Obtaining good margins of normal tissue is extremely dependent upon the skill and experience of the surgeon, and often an excessively large amount of normal breast tissue is removed to ensure that the lesion is located within the specimen. This increases the risk of post-operative complications, including bleeding and permanent breast deformity. As 80% of breast biopsies today are benign, many women unnecessarily suffer from permanent scarring and deformity from such benign breast biopsies.
• More recently, less invasive techniques have been developed to sample or biopsy the suspicious lesions to obtain a histological diagnosis. The simplest of the newer techniques is to attempt visualization of the lesion by external ultrasound. If seen by external ultrasound, the lesion can be biopsied while being continuously visualized. This technique allows the physician to see the biopsy needle as it actually enters the lesion, thus ensuring that the correct area is sampled. Current sampling systems for use with external ultrasound guidance include a fine needle aspirate, core needle biopsy or vacuum-assisted biopsy devices.
• Another conventional technique localizes the suspicious lesion using stereotactic digital mammography. The patient is placed prone on a special table that includes a hole to allow the designated breast to dangle therethrough. The breast is compressed between two mammography plates, which stabilizes the breast to be biopsied and allows the digital mammograms to be taken. At least two images are taken 30 degrees apart to obtain stereotactic views. The x, y and z coordinates targeting the lesion are calculated by a computer. The physician then aligns a special mechanical stage mounted under the table that places the biopsy device into the breast to obtain the sample or samples. There are believed to be three methods available to biopsy lesions using a stereotactic table: (1) fine needle aspiration, (2) core needle biopsy and (3) vacuum-assisted core needle biopsy.
• Fine needle aspiration uses a small gauge needle, usually 20 to 25 gauge, to aspirate a small sample of cells from the lesion or suspicious area. The sample is smeared onto slides that are stained and examined by a cytopathologist. In this technique, individual cells in the smears are examined, and tissue architecture or histology is generally not preserved. Fine needle aspiration is also very dependent upon the skill and experience of the operator and can result in a high non-diagnostic rate (up to about 83%), due to inadequate sample collection or preparation.
• Core needle biopsy uses a larger size needle, usually 14 gauge to sample the lesion. Tissue architecture and histology are preserved with this method. A side-cutting device, consisting of an inner trough with an outer cutting cannula is attached to a spring-loaded device for a rapid semi-automated firing action. After the lesion is localized, local anaesthetic is instilled and a small incision is made in the skin with a scalpel. The device enters the breast and the needle tip is guided into the breast up to the targeted lesion. The device is fired. First, the inner cannula containing the trough rapidly penetrates the lesion. Immediately following this, the outer cutting cannula rapidly advances over the inner cannula cutting a sample of tissue off in the trough. The whole device is then removed and the sample retrieved. Multiple penetrations of the core needle through the breast and into the lesion are required to obtain an adequate sampling of the lesion. Over 10 samples have been recommended by some.
• The vacuum-assisted breast biopsy system is a larger semi-automated side-cutting device. It is usually 11 gauge in diameter and is more sophisticated than the core needle biopsy device. Multiple large samples can, be obtained from the lesion without having to reinsert the needle each time. A vacuum is added to suck the tissue into the trough. The rapid firing action of the spring-loaded core needle device is replaced with an oscillating outer cannula that cuts the breast tissue off in the trough. The physician controls the speed at which the outer cannula advances over the trough and can rotate the alignment of the trough in a clockwise fashion to obtain multiple samples.
• If a fine needle aspirate, needle core biopsy or vacuum-assisted biopsy shows malignancy or a specific benign diagnosis of atypical hyperplasia, then the patient needs to undergo another procedure, the traditional needle-localized breast biopsy, to fully excise the area with an adequate margin of normal breast tissue. Sometimes the vacuum-assisted device removes the whole targeted lesion. If this occurs, a small titanium clip should be placed in the biopsy field. This clip marks the area if a needle-localized breast biopsy is subsequently required for the previously mentioned reasons.
• Another method of biopsying the suspicious lesion utilizes a large end-cutting core device measuring 0.5 cm to 2.0 cm in diameter. This also uses the stereotactic table for stabilization and localization. After the lesion coordinates are calculated and local anesthesia instilled, an incision large enough is permit entry of the bore is made at the entry site with a scalpel. The breast tissue is cored down to and past the lesion. Once the specimen is retrieved, the patient is turned onto her back and the surgeon cauterizes bleeding vessels under direct vision. The incision, measuring 0.5 to larger than 2.0 cm is sutured closed.
• The stereotactic table requires awkward positioning of the patient and may be extremely uncomfortable. The woman must lie prone during the entire procedure, which may be impossible for some patients. In addition, the lesion to be biopsied must be in the center working area of the mammography plates. This may be extremely difficult and uncomfortable for the patient if the lesion is very posterior near the chest wall or high towards the axilla.
• The woman is subjected to increased radiation exposure as multiple radiographs are required throughout the course of the procedure to: (1) confirm that the lesion is within the working area of the mammography plates, (2) obtain the stereotactic coordinates (at least two views), (3) verify the positioning of the biopsy needle prior to obtaining tissue, and (4) verify that the lesion was indeed sampled. If any difficulty is encountered during the procedure, additional radiographic exposures are required to verify correction of the problem.
• Using the core needle biopsy or vacuum-assisted device, bleeding is controlled only by manual pressure. Bleeding is generally not an issue with fine needle aspiration, but is a legitimate complication of the former two methods. Ecchymoses, breast edema and hematomas can occur. This causes increased post-procedural pain and delays healing. Rarely, the patient may require an emergency operation to control and evacuate a tense hematoma.
• Another major concern is the possibility of tumor dissemination. The core needle biopsy and vacuum-assisted devices both cut into the tumor and carve out multiple samples for examination. While cutting into the tumor, cancerous cells may be dislodged. Cutting across blood vessels at the same time may allow the freed cancerous cells access to the blood stream, thus possibly seeding the tumor beyond its original locus. The long-term consequences of tumor seeding with the risk of bloodborne metastases are unknown at this time, as the techniques are relatively new. However, documented instances of cancerous cells seeding locally into needle tracks exist. There are numerous reports of metastases growing in needle tracks from previous biopsies of a cancerous mass. Most of these are from lung or liver cancers. However, at least one case of mucinous carcinoma of the breast growing in a needle track has been reported. The long-term consequences of neoplasm seeding into needle tracks are currently unknown, again because the techniques are relatively new. Some recommend excision of the entire needle track, including the skin entry site, during the definitive surgical procedure for a diagnosed cancer, whether it is a lumpectomy or a mastectomy. Others assume that with a lumpectomy, the post-operative radiation therapy will destroy any displaced cancer cells in the needle track. With the trend towards treating very small cancers only by excision and without a post-excision course of radiation therapy, the risk of cancer cells metastasizing and growing in needle tracks is very real.
• The large core cutting device (0.5 cm to 2.0 cm) generally eliminates the risk of needle track seeding as it is designed to excise the lesion intact. A stereotactic table is required with the same inherent awkwardness for the patient, as discussed above. Bleeding is controlled, albeit manually, requiring that the patient wait until the end of the procedure to be turned over. Compression is used to stabilize the breast and localize the lesions. The breast, however, may be torqued and distorted between the compression plates such that when the plates are removed after the biopsy, the large core track left behind may not be straight, but actually tortuous. This can result in permanent breast deformity.
• The location of the insertion site into the breast is dictated by the positioning of the breast in the machine and not by the physician. The entry site is usually away from the nipple-areolar complex and is usually located on the more exposed areas of the breast. For the fine needle aspirate, core biopsy and vacuum-assisted devices, the incision is usually very small and the scar almost unappreciable. However, in the case of the large core biopsy device (0.5 to 2.0 cm), a large incision is needed. Such a large incision often results in a non-aesthetically placed scat.
• The newer conventional minimally invasive breast biopsy devices have improved in some ways the ability to diagnose mammographically detected nonpalpable lesions. These devices give the patient a choice as to how she wants the diagnosis to be made. Moreover, these devices are substantially less expensive than the older traditional needle-localized breast biopsy. They are not, however, the final solution. Due to the above-discussed problems and risks associated with compression, needle-track seeding, blood borne metastases, bleeding, radiation exposure and awkwardness of the stereotactic table, more refined devices and methods are needed to resolve these issues. Also, the conventional biopsy devices do not consider margins in their excisions and if cancer is diagnosed, the patient must undergo a needle-localized breast lumpectomy to ensure that adequate margins are removed around the cancer. Devices and methods, therefore, must address the problem of obtaining adequate margins so that a second procedure is not required. Margins, moreover, cannot be assessed while the breast is being compressed.
SUMMARY OF THE INVENTION
• It is, therefore, an object of the present invention to provide devices and methods to efficiently and safely excise suspicious lesions from the breast. It is also an object of the present invention to provide devices and methods that remove the entire lesion intact with the minimum amount of normal tissue surrounding the lesion needed to provide adequate margins. It is a further object of the present invention to provide devices and methods that provide hemostasis in the breast to minimize complications of ecchymosis, hematoma formation, and breast edema. It is another object of the present invention to provide methods and devices to provide intra-tissue ultrasonic guidance to provide real time, in situ monitoring of the procedure. A still further object is to provide devices and methods that allow the physician to minimize the size of the incision through which the procedure is performed and to leave an aesthetically acceptable scar on the breast.
• In accordance with the above-described objects and those that will be mentioned and will become apparent below, an embodiment of an excisional biopsy system according to the present invention comprises a tubular member including a proximal end and a distal end, the tubular member defining a first window near the distal end, and a first removable probe that includes a proximal portion including cutting tool extending means, a distal portion and a cutting tool near the distal portion, the first removable probe being configured to fit at least partially within the tubular member to enable the cutting tool to selectively bow out of and to retract within the first window when the cutting tool extending means are activated.
• The first removable probe may further include a window slide and the proximal end may further include a window slide extending means, the window slide being configured to selectively cover a portion of the first window when the window slide extending means are activated. The cutting tool may include one of a thin ribbon sharpened on a leading edge thereof and a wire. The cutting tool may include an RF cutting tool and the first removable probe may be adapted to be connected to an RF power source. The cutting tool may include a monopolar or a bipolar RF cutting tool. The tubular member may include a first internal guide that is configured to enable the first removable probe to slide within the tubular member. The first removable probe may include a second internal guide, the second internal guide enabling the cutting tool to slide within the first removable probe when the cutting tool extending means are activated. The first removable probe may include a third internal guide, the third internal guide enabling the window slide to slide within the first removable probe when the window slide extending means are activated. The biopsy system may further include a second removable probe comprising a proximal section including a tissue collection device extending means and a distal section including a tissue collection device, the second removable probe being configured to fit at least partially within the tubular member to enable the tissue collection device to extend out of and to retract within the first window when the tissue collection device extending means are activated. Alternatively, the tubular member may define a second window near the distal end thereof, and the biopsy system may further include a second removable probe comprising a proximal section including a tissue collection device extending means and a distal section including a tissue collection device, the second removable probe being configured to fit at least partially within the tubular member to enable the tissue collection device to selectively extend out of and to retract within the second window when the tissue collection device extending means are activated.
• The tissue collection device may include a thin ribbon or a wire, as well as a thin flexible sheet of material attached to the thin ribbon or wire, the thin flexible sheet at least partially encapsulating a tissue specimen as the thin ribbon or wire is extended and the tubular member rotated. The thin flexible sheet of material may include a bag attached to the ribbon or wire so as to open and close when the ribbon or wire is extended and retracted, respectively. The tissue collection device may include a thin ribbon or a wire, and a thin flexible sheet of material may be attached to the thin ribbon or wire, the thin flexible sheet at least partially encapsulating a tissue specimen as the thin ribbon or wire is extended and the tubular member rotated. The thin flexible sheet of material may include a bag attached to the thin ribbon or wire so as to open and close when the thin ribbon or wire is extended and retracted, respectively. The tubular member may include a first internal guide that is configured to enable one of the first and the second removable probe to slide within the tubular member until the cutting tool and/or the tissue collection device faces out of the first window. Similarly, the tubular member may include a second internal guide that is configured to enable the second removable probe to slide within the tubular member until the tissue collection device faces out of the second window. The distal portion of the first removable probe may further include a tissue collection device near a trailing edge of the cutting tool, the tissue collection device being configured to selectively extend out of and retract into the first window. The proximal portion of the first removable probe may include a tissue collection device extending means, the tissue collection device extending means being adapted to enable the tissue collection device to extend out of and to retract within the first window independently of the cutting tool. The tissue collection device may be coupled to the cutting tool and the cutting tool extending means may also be configured to selectively extend the tissue collection device out of the first window and retract the tissue collection device into the first window as the cutting tool is extended and retracted, respectively. The first removable probe may include an insulator between the tissue collection device and the cutting tool. The insulator may include an air gap and/or an insulating material attached to and separating the cutting tool from the tissue collection device. The first removable probe may define one or more internal lumens that terminate near the distal portion as an opening formed in a surface of the first removable probe, the opening being adapted to deliver a pharmaceutical agent and/or to provide suction.
• A third removable probe may be provided, the third removable probe being configured to fit at least partially within the tubular member and including an imaging device mounted therein. The imaging device may include an ultrasound sensor, such as a linear array of ultrasound transducers, for example. The ultrasound sensor may be disposed near a distal tip of the third removable probe and away from the cutting tool, so that the ultrasound sensor sweeps a plane ahead of the cutting tool as the tubular member rotates. The ultrasound sensor may be tuned within the range from about 7.5 MHz to about 20 MHz. The ultrasound sensor may be disposed within the tubular member at an angle α relative to the cutting tool, the angle α being no smaller than that necessary to effectively control the operation of the cutting tool in response to information gathered from the ultrasound transducer as the tubular member rotates. For example, the angle α may be less than about 90 degrees.
• The tubular member, first removable probe, the second removable probe and/or the third removable may be configured for a single use and may be disposable.
• The present invention is also a soft tissue treatment method, comprising the steps of inserting a generally tubular member into the soft tissue, the tubular member defining a first window in a surface thereof, the tubular member being configured to accept a removable probe inserted therein; inserting a first removable probe into the tubular member, the first removable probe including a cutting tool that is adapted to face out of the first window; selectively activating the cutting tool to cut a tissue specimen while rotating the tubular member within the tissue; removing the first removable probe from the tubular member while the tubular member stays in place; inserting a second removable probe into the tubular member, the second removable probe including a tissue collection device that is adapted to face out of the first window, and selectively activating the tissue collection device to encapsulate the tissue specimen rotating the tubular member.
• The first removable probe may be inserted into the tubular member before the tubular member is inserted into the soft tissue. The method may further include the steps of inserting a third removable probe into the tubular member, the third removable probe including an imaging device therein that is configured to face out of the first window, and rotating the tubular member while activating the imaging device to image the soft tissue at least one of before and after the tissue collection device is activated. The tubular member may define a second window in the surface thereof and the method may further include the steps of inserting a third removable probe into the tubular member, the third removable probe including an imaging device therein that is configured to face out of the second window, and rotating the tubular member while activating the imaging device to image the soft tissue at least one of before, during and after the tissue collection device is activated.
• Steps may be carried out to display information received from the imaging device on a display device and to vary the operation of the cutting tool and/or the tissue collection device during the first and/or second activating steps based upon the displayed information from the imaging device. The cutting tool may include an electrosurgical blade and the method may further include the step of varying a power applied to the electrosurgical blade based upon information received from the imaging device or feedback to the RF generator. A step of stabilizing the soft tissue in an uncompressed state prior to the first inserting step may also be carried out.
• The tubular member and/or the first removable probe may define an internal lumen and a plurality of through holes in fluid communication with the internal lumen, and the method may further comprise one or more of the following steps: delivering a pharmaceutical agent to the tissue via the plurality of through holes, and suctioning smoke and/or fluids from the soft tissue via the plurality of through holes.
• The present invention may also be viewed as a soft tissue treatment method, comprising the steps of inserting a generally tubular member into the soft tissue, the tubular member defining a first window in a surface thereof, the tubular member being configured to accept a removable probe inserted therein; inserting a first removable probe into the tubular member, the first removable probe including a cutting tool and a tissue collection device that are adapted to face out of the first window; selectively activating the cutting tool to cut a tissue specimen while rotating the tubular member within the soft tissue, and selectively activating the tissue collection device to encapsulate the tissue specimen while rotating the tubular member.
• The first removable probe may be inserted into the tubular member before the tubular member is inserted into the soft tissue. The tubular member may define a second window in the surface thereof and the method may further include the steps of inserting a second removable probe into the tubular member, the second removable probe including an imaging device therein that is configured to face out of the second window, and rotating the tubular member while activating the imaging device to image the soft tissue at least one of before, during and after at least one of the cutting tool and the tissue collection device are activated. The method may also include the steps of displaying information received from the imaging device on a display device; and varying an operation of at least one of the cutting tool and the tissue collection device during at least one the first and second rotating steps based upon the displayed information from the imaging device.
• The first and second activating steps may be carried out simultaneously and the cutting tool and the tissue collection device may be coupled to one another. Alternatively, the first and second activating steps may be carried out simultaneously or consecutively and the cutting tool and the tissue collection device may be activated independently of one another.
• According to another embodiment thereof, the present invention is also an excisional biopsy system for soft tissue, comprising a tubular member defining a first, a second and a third window near a distal tip thereof; a first removable probe comprising a proximal portion that includes cutting tool extending means, a distal portion and a cutting tool near the distal portion, the first removable probe being configured to fit at least partially within the tubular member to enable the cutting tool to selectively bow out of and to retract within the first window when the cutting tool extending means are activated; a second removable probe comprising a proximal section including a tissue collection device extending means and a distal section including a tissue collection device, the second removable probe being configured to fit at least partially within the tubular member to enable the tissue collection device to extend out of and to retract within the second window when the tissue collection device extending means are activated, and a third removable probe, the third removable probe being configured to fit at least partially within the tubular member and including an imaging device mounted therein that is configured to face out of the third window.
• The present invention may also be viewed as an excisional biopsy system for soft tissue, comprising a tubular member defining a first and a second window near a distal tip thereof; a first removable probe comprising a proximal portion and a distal portion, the proximal portion including a tool extending means, the distal portion including a cutting tool and a tissue collection tool, the first removable probe being configured to fit at least partially within the tubular member to enable the cutting and tissue collection tools to selectively extend out of and to retract within the first window when the tool extending means are activated, and a second removable probe, the third removable probe being configured to fit at least partially within the tubular member and including an imaging device mounted therein that is configured to face out of the second window.
• The cutting and tissue collection tools may be mechanically coupled to one another. The cutting and tissue collection tools may also be independently activated and the tool extending means may include a cutting tool extending means operative to extend and to retract the cutting tool out of and into the first window and a tissue collection extending means operative to extend and to retract the tissue collection tool into and out of the first window.
BRIEF DESCRIPTION OF THE DRAWINGS
• For a further understanding of the objects and advantages of the present invention, reference should be made to the following detailed description, taken in conjunction with the accompanying figures, in which:
• FIG. 1A shows an embodiment of the excisional device according to the present invention with the cutting tool in its flat, retracted configuration.
• FIG. 1B shows the excisional device ofFIG. 1A with its cutting tool in an extended, bowed configuration.
• FIG. 1C shows another view of the excisional device ofFIG. 1A.
• FIG. 2A depicts the distal region of another embodiment of the excisional device according to the present invention, showing the excisional device together with the external tissue collection attached thereto in the open configuration.
• FIG. 2B shows the excisional device ofFIG. 2A together with the external tissue collection attached thereto in the closed configuration.
• FIG. 2C shows an embodiment of the proximal region of the excisional device according to the present invention.
• FIG. 3A depicts the operation of an embodiment of the excisional device and method according to the present invention.
• FIG. 3B further shows the operation of an embodiment of the excisional device and method according to the present invention.
• FIG. 3C further depicts the operation of an embodiment of the excisional device and method according to the present invention.
• FIG. 4 shows a detailed view of a cutting tool suitable for use with the excisional device according to the present invention.
• FIG. 5 shows a cross section of the cutting tool, taken along line AA′ inFIG. 4.
• FIG. 6 shows a detailed view of another cutting tool suitable for use with the excisional device according to the present invention.
• FIG. 7 shows a cross section of the cutting tool, taken along line BB′ inFIG. 6.
• FIG. 8 shows another embodiment of a cutting tool suitable for use with the excisional biopsy device according to the present invention.
• FIG. 9 is a cross-sectional schematic of thetubular member110, to illustrate the relative placements of thecutter window120 and of thetransducer270 about the circumference of thetubular member110. Unnecessary details have been omitted for clarity.
• FIG. 10 shows an excisional device according to another embodiment of the present invention, in which the tubular member of the excisional device includes an internal lumen through which a removable transducer core may be inserted.
• FIG. 11 shows an embodiment of a removable transducer core according to the present invention.
• FIG. 12 shows a cross section of the embodiment of the excisional device ofFIG. 10, taken along line AA′.
• FIG. 13 shows the removable transducer core ofFIG. 11 inserted within an expandable sheath, according to a further embodiment of the present invention.
• FIG. 14 shows another embodiment of a soft tissue excisional device assembly according to the present invention, in which a removable transducer core is inserted and secured within the excisional device so that the active element faces out of the transducer window.
• FIG. 15 shows another embodiment of a cutting tool (and method of making same) that is suitable for use within the excisional device according to the present invention.
• FIG. 16 shows a view of the completed cutting tool ofFIG. 15.
• FIG. 17 shows an embodiment of the method of excisional biopsy method according to the present invention.
• FIG. 18 is a top view of a removable cutting probe, according to an embodiment of the present invention.
• FIG. 19 is a side view of the removable cutting probe ofFIG. 18, showing the adjustable window slide in a first position, according to an embodiment of the present invention.
• FIG. 20 is a side view of the removable cutting probe ofFIG. 18, showing the adjustable window slide in a second position, according to an embodiment of the present invention.
• FIG. 21 is a top view of a removable tissue collection probe, according to an embodiment of the present invention.
• FIG. 22 is a detail view of a removable tissue collection probe ofFIG. 21.
• FIG. 23 is a side view of the removable tissue collection probe ofFIG. 21, showing the tissue collection device thereof in an extended (bowed) configuration.
• FIG. 24A is a top view of a removable cutting and tissue collection combination probe, according to an embodiment of the present invention.
• FIG. 24B is a partial cross-sectional view of the removable cutting and tissue collection combination probe ofFIG. 24A, taken along lines AA′.
• FIG. 25 is a top view of a removable cutting and tissue collection combination probe, according to another embodiment of the present invention.
• FIG. 26 is a side view of a removable cutting and tissue collection combination probe, according to a still further embodiment of the present invention, wherein the cutting device and tissue collection devices are shown in their extended configuration.
• FIG. 27A is a partial cross-section of a tissue collection probe, taken at the level of the tissue collection device thereof, wherein the tissue collection device is in its initial, non-extended configuration.
• FIG. 27B is a partial cross-section of a tissue collection probe ofFIG. 27A, wherein the tissue collection device is in its extended configuration.
• FIG. 27C is a partial cross-section of a tissue collection probe ofFIG. 27B, wherein the tissue collection device has returned to its non-extended configuration after capturing the target tissue.
• FIG. 28 is a flowchart of a soft tissue treatment method, according to another embodiment of the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
• FIGS. 1A, 1B and1C show an embodiment of thedistal region105 of theexcisional biopsy device100 according to the present invention. ConsideringFIGS. 1A, 1B and1C collectively, thedistal region105 of theexcisional biopsy device100 includes a generallytubular member110 having a generally tapereddistal tip115. Thedistal tip115 is configured to penetrate soft tissue, such as breast tissue, lung tissue, liver tissue and the like. Preferably, therefore, thedistal tip115 and thedistal region105 of theexcisional biopsy device100 present a smooth, and relatively atraumatic profile to the soft tissue in which it is designed to penetrate. Alternatively, thetip115 may be sharply pointed and/or may include an energy source (not shown) to facilitate cutting through the tissue. Thetubular member110 may be formed of rigid and hard plastic, or may be made of stainless steel, for example. Preferably, thetubular member100 is used once and disposed of, for both safety and functional reasons.
• Acutter window120 is disposed within thetubular member110. Thecutter window120 may be, for example, a shallow trench formed in thetubular member110. As best seen inFIG. 1C, thecutter window120 may be a shallow and substantially rectangular trench in thetubular member110, or may be, for example, a thin, shallow I-shaped trench. Theexcisional biopsy device125 includes a work element, such as acutting tool125. The distal end of thecutting tool125 is attached to thetubular member110 near itsdistal tip115. For example, the distal end of thecutting tool125 may be attached to thedistal-most point121 of thecutter window120. Thecutting tool125, however, may alternatively be attached to other points within thedistal region105. The distal portion of thecutting tool125 is exposed through thecutter window120. The remaining portion of thecutting tool125 is disposed within an internal guide orlumen130 of the generallytubular member110. Theinternal guide130 constrains the movement of thecutting tool125 and allows thecutting tool125 to freely slide therein, parallel to the longitudinal axis of thetubular member110. With particular reference now toFIG. 2C, theproximal portion225 of thecutting tool125 emerges from theinternal lumen130 near theproximal end215 of thetubular member110. The proximal end of thecutting tool125 may, for example, include a push or turnknob226. The push or turnknob226 allows the operator of theexcisional biopsy device100 to selectively push thecutting tool125 in the distal direction (away from the physician and toward the distal tip115) or retract thecutting tool125 in the proximal direction (toward the physician and away from the distal tip115). To assist in controlling the movement of thecutting tool125, the cutting tool is preferably biased in the proximal direction, as symbolized by thearrow227 inFIG. 2C. This biasing may be effectuated by means of aspring228 attached at or near theproximal end215 of thetubular member110 and to theproximal portion225 of thecutting tool125. In this manner, the default configuration of thecutting tool125 is the retracted position, wherein thecutting tool125 lies substantially flat within thecutter window120 of thetubular member110.
• Thecutting tool125, when pushed in the distal direction by the physician applying pressure in the distal direction on the push or turnknob226 or equivalent structure, slides within theinternal guide130 of thetubular member110. As the distal end of thecutting tool125 is attached near the distal end of thetubular member110 or to thedistal-most point121 of thecutter window120, the portion thereof exposed through thecutter window120 tends to bow outwardly, extending out of thecutter window120, as shown inFIG. 1B. The extension out of thecutter window120 and the degree of bowing may be controlled by the physician, by appropriate action on the push or turnknob226. Thus, the possible range of extension and bowing is potentially infinite, being limited only by the physician's ability to control thecutting tool125 by finely pushing and retracting the push or turnknob226. The degree of extension, as well as the shape of the bowed portion of the cutting tool, therefore, may be controlled by selectively sliding the cutting tool within theinternal guide130 of thetubular member110.
• The shape of the bowed portion and the ease with which the distal portion of thecutting tool125 bows outwardly may be varied by varying the physical characteristics of thecutting tool125. Preferably, the cutting tool is formed of a resilient, readily deformable material that, when unstressed, returns to its original unbiased configuration. For example, a nickel titanium alloy may be used for thecutting tool125, to allow thecutting tool125 to exhibit shape-memory characteristics. The shape of thecutting tool125 in its bowed and extended configuration (FIG. 2) may be further controlled by varying, for example, the thickness of the cutting tool over the portion thereof exposed through thecutter window120. A locally thicker portion of thecutting tool125 will not bend as readily as a locally relatively thinner portion thereof. Judiciously varying the thickness, for example, of thecutting tool125, therefore, allows the curvature of the bowed portion thereof to be controlled.
• As shown inFIGS. 1A, 1B, and with reference toFIG. 1C, pushing on the push or turn knob226 (or any such functionally equivalent structure) causes thecutting tool125 to bow outwardly and extend out from thecutter window120 of thetubular member110, as shown inFIG. 1B. Similarly, retracting the push or turn knob226 (or any such functionally equivalent structure) causes thecutting tool125 to flatten out within thecutter window120 and to assume a configuration (shown inFIG. 1A) that may be substantially flush with the outer surface of thetubular member110. In this configuration, thetubular member110 may easily penetrate soft tissue, such as breast, lung, liver or other soft body tissue.
• In operation, the surgeon makes an incision into the patient's skin, such as the surface of the breast. Theexcisional biopsy device100 then may be directly introduced into the breast tissue, or an expandable sheath (shown atreference numeral495 inFIG. 13) may be introduced into the incision and thereafter expanded as theexcisional biopsy device100 is introduced therein. In any event, the excisional biopsy device is introduced into the breast tissue itself and positioned, for example, adjacent to the lesion in the breast or adjacent the target site from which the excision is to take place. During the introduction of theexcisional biopsy device100 into the soft tissue, thecutting tool125 is in its retracted configuration wherein the portion thereof exposed through thecutter window120 is substantially flat. Theexcisional device100, in this configuration, therefore, exhibits a smooth and tapered profile to the surrounding tissue. Once thedevice100 has been determined to have been properly positioned within the soft tissue, the device is rotated about its longitudinal axis. The rotation may be carried out manually, or the rotation of the device may be carried out by a motorized unit disposed within the proximal region of thedevice100. As thedevice100 rotates, the surgeon causes thecutting tool125 to bow outwardly and to extend from thecutter window120. Preferably, the degree of bowing and outward extension is at least sufficient to include the lesion (such as the targeted microcalcification within the breast) within the space between thecutter window120 and thecutting tool125. Thecutting tool125 cuts the tissue as thedevice100 is rotated, thereby severing the lesion from its surrounding breast tissue mass. By completing at least one revolution within the breast tissue, thecutting tool125 sweeps a volume of revolution of breast tissue and severs that volume from the main tissue mass. Such volume of revolution includes at least the targeted lesion. Preferably, the volume of revolution severed from the main tissue mass not only includes the targeted lesion, but also includes a margin of healthy tissue surrounding the lesion. The degree of extension and bowing of thecutting tool125 may be varied within a given revolution of theexcisional biopsy device100. In this manner, it is possible to exert fine control over the amount of tissue cut away from the main tissue mass, as well as fine control over the shape of the severed mass.
• After the lesion and preferably a margin of healthy tissue around the lesion have been severed, the severed tissue may be removed from the main tissue mass. This removal of the severed tissue may be effectuated by any number of means, including the retraction of theexcisional biopsy device100 from the main tissue mass. Alternately, severed tissue extraction may be carried out by means of the structure and method to be described below.
• Thecutting tool125 may, as shown inFIG. 1C, be configured as a thin ribbon. Thethin ribbon125 shown inFIG. 1C is preferably sharpened on its leading edge to facilitate cutting through tissue and sometimes fibrous and calcified masses. The leading edge of thecutting tool125 is that edge thereof that first comes into contact with the tissue to be severed as thedevice100 is rotated. Such a sharpened leading edge is shown inFIG. 4 atreference numeral127. The width of such aribbon cutting tool125 is preferably smaller than the width of thecutter window120 into which it recedes when thecutting tool125 is retracted in the proximal direction.
• Another embodiment of thecutting tool125 is shown inFIG. 8. To decrease the forward resistance of thecutting tool125 as it slowly cuts through tissue, the leading edge of the portion thereof exposed through thecutter window120 may be serrated, including a plurality ofteeth127. In turn, the leading edge of the plurality ofteeth127 may include a sharpened edge. In this manner, as theexcisional device100 rotates, only the forward-most tips of theteeth127 will initially come into contact with the tissue to be cut, thus reducing the tissue surface upon which the force of therotating cutting blade125 is applied. Thus, thecutting blade125 ofFIG. 8 is believed to be highly effective in cutting through even relatively dense or fibrous tissue while minimizing the torque to be applied to theexcisional biopsy device100 as it is caused to rotate within the main soft tissue mass.
• Referring toFIG. 4 and also toFIG. 5, thecutting tool125 may further comprise aninterior lumen128 running an entire length or a portion of the length of thecutting tool125. Thecutting tool125 may further include a plurality of throughholes126 in the distal portion of thecutting tool125 exposed through thecutter window120. The plurality of throughholes126 are in fluid communication with theinternal lumen128. In use, theinternal lumen128 may be connected, in the proximal portion of theexcisional biopsy device100, to a fluid reservoir. The fluid reservoir, which may be internal or external to the proximal section of thedevice100, supplies the distal portion of thecutting tool125 with, for example, anaesthetic (such as, for example, lidocaine) and/or antibiotic fluid. In this manner, such anaesthetic and/or antibiotic fluid (or other fluid) may be delivered precisely to the tissue surrounding thecutting tool125 as it rotates. A precisely dosed anaesthetic, for example, may be delivered to the very site where it is most needed. As such anaesthetic is delivered only where it is needed, the effect thereof is near instantaneous, and the patient feels little or no pain as theexcisional biopsy device100 according to the present invention is rotated within her breast, or other soft tissue.FIG. 5 shows a cross-section of thecutting tool125 ofFIG. 4, taken along line AA′ inFIG. 4.
• Care should be exercised in selecting the configuration and materials for thecutting tool125 shown inFIGS. 4 and 5. Indeed, the configuration and materials selected should allow thecutting tool125 to bow and extend out of thecutter window120 of thedevice100 without, however, pinching or substantially disrupting the flow of fluid delivered via theinternal lumen128 of thecutting tool125, if thecutting tool125 is provided with such. For example, thecutting tool125 may be made of a shape-memory metal, such as nickel-titanium and/or the proximal portion of thecutting tool125 may be formed relatively thicker than other portions thereof.
• Another embodiment of thecutting tool125 is shown inFIGS. 15 and 16. As shown therein, thecutting tool125 may be formed by a thin sheet of steel or shape memory alloy. The sheet may include a plurality of throughholes126 to allow the anaesthetic or other fluid to be instilled therethrough. Asmall tube540 may be disposed on the sheet, aligned with the throughholes126. The sheet may be folded in the direction indicated by thearrows530, thus securing thetube540 between the two folded sides of the sheet. Theedges550 of the sheet may be sealed together to render them fluid tight. For example, thesides550 of the sheet may be welded together or secured by other means known to those of skill in the metal working arts. Theedges560 between the throughholes126 may be sharpened, to allow thecutting tool125 to efficiently cut through soft tissue. As shown inFIG. 16, thetube540 may deliver anaesthetic or other fluid to thecutting tool125, which delivers minute amounts thereof precisely where it is needed: where the cutting edges560 of thecutting tool125, thereby affording the patient immediate relief and minimizing the amount of anaesthetic that need be delivered. The proximal end of thetube540 may be in fluid communication with an anaesthetic reservoir (not shown) and/or an anaesthetic pump (also not shown).
• Alternatively, thecutting tool125 may include a thin wire, such as shown at125 inFIGS. 6 and 7. In this case, an external radio frequency (hereafter, RF) power source240 (shown at240 inFIG. 2C) supplies thecutting tool125 with RF energy via two bipolar electrodes (not shown) attached to thecutting tool125 ofFIG. 6. Other energy sources may also be used within the context of the present invention, RF power being discussed herein for illustrative purposes only. The RF power delivered by theRF power source240 allows thecutting tool125 ofFIG. 6 to become an electrosurgical cutting and/or an electrocoagulating tool by selectively varying the power applied to thecutting tool125. Suitable generators for such anelectrosurgical cutting device125 are known to those of skill in this art. An example of such a suitable generator is described in U.S. Pat. No. 4,903,696 issued Feb. 27, 1990 and assigned to Everest Medical Corporation, Brooklyn Center, Minn., the disclosure of which is incorporated herewith in its entirety. As with thecutting tool125 shown inFIGS. 4 and 5, thecutting tool125 ofFIGS. 6 and 7 includes aninternal lumen128 and a plurality of throughholes126 to allow anaesthetic or other fluid to be delivered to the surrounding tissue as thecutting tool125 cuts through the soft tissue as thedevice100 is rotated.
• As alluded to above, theexcisional biopsy device100 according to the present invention cuts out a (not necessarily symmetrical) volume of revolution as it cuts through the soft tissue upon rotation of the generallytubular member110. This severed mass of tissue may be stabilized using an extendable tissue anchoring device, which anchoring device also assists in the retrieval of the severed tissue sample from the breast. The anchoring device may, for example, include a suction device or other substantially rigid anchor member to anchor the tissue sample. Alternatively, the severed tissue sample may be collected in a tissue collection device, as shown atreference numeral260 inFIGS. 2A and 2B. Thetissue collection device260 is attached externally to thetubular member110, and preferably also to the trailing edge of thecutting tool125. Thetissue collection device260 is preferably formed of a thin and flexible plastic membrane shaped like a bag. The opening of the bag-shapedcollection device260 is preferably co-extensive with theopening120 and is preferably attached to thetubular member110 and to the trailing edge of thecutting tool125. In this manner, the opening or “mouth” of the bag-shapedcollection device260 opens and closes along with the bowing and retraction, respectively, of thecutting tool125. Indeed, the “mouth” of the bag-shapedcollection device260 is opened when thecutting tool125 is bowed and extended out of thecutter window120 and substantially closed when the same is retracted within thecutter window120, as the two edges (one attached to thetubular member110 just adjacent to the edge of thecutter window120 and the other attached to the trailing edge of the cutting tool125) of the collection device are then pressed together.
• Therefore, when theexcisional device100 is inserted into soft tissue and rotated, thecutting tool125 may be caused to bow and to extend outwardly from thecutter window120 and caused to cut tissue coming into contact therewith. As thedevice100 rotates and cuts, the tissue between the cuttingtool125 and thetubular member110 tends to advance toward and into the collection device. As thecutting tool125 is in it's bowed and extended state, the “mouth” or opening of the bag-shapedcollection device260 is also correspondingly open, allowing the severed tissue to collect therein. As the revolution of thetubular member100 is completed, thecutting tool125 may be retracted and caused to assume a configuration wherein it is disposed within the recessedcutter window120, substantially flush with the outer surface of thetubular member110, as shown inFIG. 2B. In this configuration, thecollection device260 is closed, thereby securing the excised tissue sample therein. Thedevice100 may then be safely retracted from the main tissue mass, such as the breast. As the excised sample is physically isolated from the remaining tissue mass, the probability of seeding the surrounding tissue with potentially abnormal cells is markedly decreased. This probability is also further decreased, as theexcisional device100 according to the present invention allows the surgeon to obtain adequate margins of healthy tissue surrounding the target lesion by choosing the degree of bowing and extension of thecutting tool125. In this manner, the integrity of the lesion itself is not violated, thereby maintaining tissue architecture intact.
• As thecollection device260 is preferably formed of a thin and flexible membrane, it is able to lay substantially flat against the outer surface of thetubular member110 or slightly recessed within thecutter window120 during insertion thereof into the soft tissue. Thecollection device260, therefore, offers little additional drag and resistance to thedevice100 as it is inserted into the incision made in the patient's skin during or prior to the procedure. Suitable materials for thetissue collection device260 include plastics and nylon, for example. Any strong adhesive may be utilized to secure thetissue collection device260 to thetubular member110 and to thecutting tool125. Other means of securing thecollection device260 may also be employed without, however, departing from the scope of the present invention. Likewise, thetissue collection device260 may be formed of a material other than specifically enumerated herein while remaining within the spirit of the present invention. Preferably, the shape and size of thetissue collection device260 are such as to minimize drag on theexcisional biopsy device100 as it is inserted and rotated into the tissue. For example, thetissue collection device260 preferably should be only as large as necessary to contain the excised tissue sample.
• Theexcisional biopsy device100 according to the present invention is preferably accurately positioned adjacent to the lesion within the breast or other organ. Toward that end, the present invention allows the surgeon to gain near real time or real time information as to the internal structure of the soft tissue during the procedure itself. Referring now back toFIGS. 1 and 2C, the present invention may include atransducer270 mounted within the distal portion of thetubular member110. Thistransducer270 is preferably adapted to image tissue about to be cut by thecutting tool125 as theexcisional biopsy device100 is rotated within the soft tissue. Indeed, thetransducer270 preferably generates information relative to the tissue about to be cut—that is, tissue that that has not yet been brought into contact with thecutting tool125 as thetubular member110 rotates about its longitudinal axis. In this manner, as the rotational speed of theexcisional biopsy device100 is preferably quite slow (the rotation may be manually carried out or may be caused by a slow moving motorized unit attached to the tubular member110), the surgeon may evaluate the information generated by thetransducer270 and may, based upon this information, vary the degree of bowing and extension of thecutting tool125. For example, when thedevice100 is positioned adjacent to the lesion of interest and rotated, thetransducer270 will detect the presence and location of the lesion before the lesion comes into contact with thecutting tool125. After the lesion has been detected by thetransducer270, the surgeon may push on the push or turnknob226 or other structure that causes the cutting tool to bow and extend from thecutter window120. The lesion (and preferably an adequate margin of healthy tissue) will then be severed from the main mass, and optionally collected, for example, in thetissue collection device260. When thetransducer270 indicates that the rotation of the tubular member has brought thecutting tool125 past the lesion, thecutting tool125 may be retracted within thecutter window120. The cutting, it can be seen, may be specifically tailored to the size and shape of the lesion within the main tissue mass in near real time or in real time, thereby allowing the surgeon to excise all of the tissue required and only the tissue that is necessary to achieve the intended results.
• Preferably, thetransducer270 is an ultrasound sensor mounted substantially flush with the external surface of thetubular member110. Theultrasound sensor270 is preferably electrically connected, via a communication channel such as electrical conductors, to at least one data processing and display device, shown atreference250 inFIG. 2C. The data processing and display device(s)250 allows the surgeon to see, in near real time or in real time, the internal structure of the tissue about to be cut by thecutting tool125. This allows the surgeon not only to see a graphical representation of the internal structure of the tissue during the procedure itself, but also allows the surgeon to assure himself or herself that the entire lesion or group of lesions has been properly excised by, for example, rotating the tubular device within the tissue while the cuffing tool is retracted within thecutter window120 while thetransducer270 is energized. Viewed from another aspect, therefore, the present invention is an intra-tissue ultrasound imaging device that may, but need not include a cutting tool, such as referenced by numeral125 in the figures.
• In operation, the (e.g., ultrasound) transducer sweeps a plane (graphically shown at280 inFIG. 3A) within the tissue ahead of the work element, such ascutting tool125. In selecting the operational characteristics of theultrasound transducer270, the surgeon must balance the required resolution (i.e., the smallest feature that must be discernable) with the degree of penetration of the ultrasound waves within the tissue and the intensity of the ultrasonic waves generated. In general, higher frequencies allow better resolution. However, high frequencies do not penetrate the tissue as far as do lower frequency ultrasound waves. Preferably, theultrasound transducer270 is tuned within the range from about 5 MHz to about 20 MHz. More preferably, theultrasound transducer270 is tuned within the range of about 7.5 MHz to about 20 MHz. For example, in the case wherein theexcisional biopsy device100 according to the present invention is used within the female breast, the ultrasound transducer may be tuned within the range of about 10 MHz to about 13 MHz.
• To effectively image the internal tissue structure prior to cutting it with, for example, thecutting tool125, thetransducer270 must be positioned within thetubular member110 away from thecutting tool125. With reference toFIG. 9, thetransducer270 may be disposed within the tubular member at an angle α relative to thecutting tool125. The angle α is preferably no smaller than that necessary to effectively control the operation of the work element (such as cutting element125) in response to information gathered from thetransducer125 as thetubular member110 rotates. This angle α, therefore, is dependent at least upon the rotational speed imposed upon thetubular member110 and upon the time necessary for the surgeon to assimilate the information generated by the transducer and to effectively control thecutting tool125 in response to such information. Preferably, the angle α is less than about 180 degrees.
• When used in conjunction with an intra-tissue ultrasound transducer, such as shown at270, theexcisional biopsy device100 according to the present invention may include a variety of work elements in place of or in addition to thecutting tool125. Such work elements include, for example, an abrasive device, a reciprocating cutting device, an electrosurgical device or a vibrating device.
• In the case of lesions within the breast, it is useful to stabilize the breast prior to imaging and performing invasive procedures. Such stabilization is conventionally performed by compression plates that squeeze the breast and compress the tissue therein. Such compression is necessary to allow x-ray radiation, as used in mammography, to produce a useful image. Although such compression is not needed or believed to be desirable according to the present invention, stabilization of the breast remains necessary. For this purpose, the breast stabilization devices described in commonly assigned U.S. patent application Ser. No. 09/158,215 entitled “Breast Stabilization Devices And Methods” filed on Sep. 22, 1998, and Ser. No. 09/200,661 entitled “Breast Stabilization Devices And Imaging And Interventional Methods Using Same” filed on Nov. 25, 1998, the disclosures of each being incorporated herein in their entirety, may be useful.
• Reference is now made toFIGS. 3A, 3B and3C, which illustrate an embodiment of the excisional biopsy method according to the present invention. AlthoughFIGS. 3A-3C illustrate an embodiment of the present invention within the context of breast surgery, it is to be understood that the present inventive method is equally applicable to other soft tissue masses, such as, for example, lung, thyroid or liver tissue, with only minor modifications that will become apparent to skilled practitioners in this art.
• Turning first toFIG. 3A, asmall incision331 is made in thebreast310, preferably in the peri-areolar region. Preferably, the breast is stabilized, using, for example, the breast stabilizing devices disclosed in U.S. patent application Ser. No. 09/158,215 or 09/200,661 referred to above. The portion of thedevice100 that remains outside of the soft tissue may include attachment means (not shown) for clamping the device to a rim structure, for example, to allow stable operation and precise guidance thereof. The small incision is preferably made on the border of theareola330 surrounding thenipple320, as this provides a better cosmetic scar than on the skin on the side of thebreast310. Depending on the size of the lesion and the size of theexcisional biopsy device100 to be inserted therein, an expandable sheath (an example of which is shown atreference numeral495 inFIG. 13) may be inserted into the breast tissue. In any event, theexcisional biopsy device100 is inserted into the breast tissue and positioned adjacent thelesion300, which may be, for example, a microcalcification or other abnormal lesion. Once in position, thedevice100 is rotated, for example, in the direction indicated inFIG. 3A. The portion of theexcisional biopsy device100 that remains outside the soft tissue may have a greater diameter than the portion thereof that is designed to penetrate the soft tissue. This aids in manual rotation of thedevice100. In the configuration depicted inFIG. 3A, thecutting tool125 is retracted within thecutter window120 and thetissue collection device260, if present, is substantially flat against the external surface of thetubular member110. Thedevice110 is rotated about its longitudinal axis and thetransducer270 is energized, the information therefrom being transmitted to, for example, thedisplay device250 shown inFIG. 2C. When thelesion300 comes into view, the surgeon then gauges the size, shape and location thereof and controls the bowing and extension of the work element, such ascutting tool125 based on the information received from thetransducer270 and displayed upon thedisplay250.FIG. 3B depicts the situation wherein thelesion300 has been imaged and the surgeon has extended thecutting tool125 to sever thelesion300 from the surrounding breast tissue. The severed tissue may be received and collected in atissue collection device260, as thedevice100 rotates. Anaesthetic and/or antibiotic (or other) fluids may be delivered directly to the affected tissue by through holes126 (best seen inFIGS. 2A, 2B andFIGS. 4-7), greatly decreasing pain during the procedure.
• After the lesion and any desired margin of healthy tissue is severed from the main breast tissue mass, thecutting tool125 is retracted within thecutter window120. This closes thetissue collection device260, if present, and allows theentire device100 to be retracted from the breast in the direction ofarrow350, as shown inFIG. 3C. If thetissue collection device260 is present, thelesion300 will be isolated from surrounding tissue by the membrane of thetissue collection device260, thus minimizing any possibility of seeding potentially abnormal cells to surrounding breast tissue. Moreover, the tissue architecture of the retrievedlesion300 is substantially preserved, thereby allowing accurate histopathology to be performed upon the entire mass excised from the breast. Indeed, any compression such tissue may undergo is believed to be solely due to the retraction of the device back through the entrance track of thedevice100 in the uncompressed breast tissue. Thereafter, when theexcisional device100 is removed from thebreast310, the push or turnknob226 may be acted upon to extend and bow thecutting tool125, thereby allowing the excised lesion to be retrieved from thetissue collection device260 for examination. If the tissue collection device is not present, conventional suction means may be employed to extract the severed lesion from the surrounding breast tissue. Bleeding is controlled by suitably varying the RF or other power source applied to theelectrosurgical cutting tool125, if present, to stem the bleeding by cauterizing the tissue coagulating the blood.
• After the procedure, a small cavity remains in the breast where the lesion had previously been. However, since no compression of the breast was carried out, no expansion of the tissue occurs after the procedure, unlike conventional techniques. Therefore, the cavity and the entrance and exit path of the device remain as small as possible, leading to fewer complications, less tissue trauma and improved aesthetics.
• According to another embodiment of the present invention, shown inFIGS. 10, 11 and12, thetransducer270 is replaced by aremovable transducer core400. Theremovable transducer core400 includes anactive element440 configured to perform intra-tissue imaging and of relaying information back to a display device (shown inFIG. 14) via a communication channel, such as shown atreference numeral460. Thecommunication channel460 may be wireless or may include, for example, optical fibers and/or electrical conductors. Theactive element440 may draw power from an internal battery (not shown) or from a power source, such as shown atreference numeral480. Theactive element440 may include an ultrasound transducer. Other types of transducers may be used instead of or in addition to an ultrasound transducer. Theremovable transducer core400 preferably includes a generallytubular shaft430. Aproximal section450 is included near the proximal portion of thetransducer core400.
• To accommodate theremovable transducer core400, theexcisional device100 ofFIG. 10 defines aninternal lumen420 through which theremovable transducer core400 may be inserted. Preferably, theexcisional device100 is used once and disposed of, for safety and functional reasons. Theremovable transducer core400, however, may either be disposable or re-usable for a limited number of uses. To allow theactive element440 of thetransducer core400 to image the lesion to be excised and the surrounding tissue, the generallytubular member110 of theexcisional device100 includes atransducer window410. When theremovable transducer core400 is inserted within theinternal lumen420, theproximal section450 of the core400 preferably snaps into a locked configuration with the proximal end of theexcisional device100. When in its locked configuration, theactive element440 of thetransducer core400 is aligned with and faces thetransducer window410, to allow theactive element440 to image the lesion and the surrounding tissue therethrough. To facilitate insertion of thetubular member110 in the patient's soft tissue the distal-most tip thereof may include an (mono or bipolar) RF electrosurgical element or wire, as indicated at reference numeral116, which may be energized by an RF source, as shown at240 inFIGS. 2C and 14.
• FIG. 11 shows an embodiment of theremovable core400 according to the present invention. As theremovable core400 may advantageously be used independently of theexcisional device100, theremovable core400 includes a distal taperedtip470, to allow it to easily penetrate soft tissue. Moreover, its thin profile allows the surgeon to insert theremovable core400 within soft tissue without, however, unduly damaging the tissue or making a large incision. Theremovable core400 allows the surgeon to precisely localize the lesion to be excised from within the tissue itself. For example, theactive element440 of theremovable core400 may include an ultrasound transducer having similar characteristics as thesensor270, and may be used alone or in addition to surface ultrasound to localize the lesion with a great degree of precision.
• FIG. 12 shows a cross section of the embodiment of theexcisional device100 ofFIG. 10, taken along line AA′. As shown inFIG. 12, thecutting tool125 is exposed through thecutter window120. Thewindow120 may, as shown inFIG. 12, include support guides122 to support and guide thecutting tool125 as it is outwardly extended and bowed. Thetissue collection device260, for clarity, is not shown in eitherFIG. 10 or12. However, to accommodate the bulk of the excised tissue sample collected in thetissue collection device260 after the cutting and collecting operation described herein, thetubular member110 may include a recessedsection131. The recessed section provides space for the collected (e.g., bagged) tissue sample in thetissue collection device260 when the excisional device is removed from the soft tissue mass. In this manner, the collected tissue sample within thetissue collection device260 does not protrude from the generally smooth outer surface of theexcisional device100 upon retraction of the latter from the soft tissue mass from which the tissue sample is excised. Theinternal lumen420 allows theremovable core400 to slide therein and to properly position theactive element440 facing thetransducer window410.
• FIG. 13 shows theremovable core400 inserted within anexpandable sheath495. The expandable sheath includes aproximal base section510. Attached to theproximal base section510 is a generally cylindricalexpandable meshwork500 of, for example, plastic or nylon fibers. Themeshwork500 may be somewhat tapered at itsdistal end520, to provide a smooth transition between theexpandable meshwork500 and theremovable core device400. Theproximal section450 of thecore400 may snap-fit to theproximal base section510 of theexpandable sheath495, so as to be securely and removably attached thereto. As shown inFIG. 13, theexpandable meshwork500 expands just enough to accommodate theremovable core400 inserted therein. In practice, theexpandable sheath495 andremovable core400 assembly may be inserted within the soft tissue together, to allow the surgeon to image the lesion prior to inserting the somewhat greater diameterexcisional device100 therein. Thereafter, the surgeon may retract theremovable core400 from theexpandable sheath495, leaving theexpandable sheath495 in place within the soft tissue, such as the breast.
• FIG. 14 shows another embodiment of a soft tissueexcisional device assembly600 according to the present invention. In the configuration shown inFIG. 14, theremovable core400 is inserted and secured within theexcisional device100 so that theactive element440 faces out of thetransducer window410. As inFIG. 10, thetissue collection device260 is not shown, for clarity. InFIG. 14, theexcisional device100 is shown inserted within theexpandable sheath495. Indeed, theexcisional device100, inFIG. 14, is shown inserted within and past thedistal end520 of themeshwork500, so the distal portion of theexcisional device100 including thecutting tool125 and thetransducer window410 extends therethrough. Themeshwork500, inFIG. 14, has expanded to accommodate the diameter of theexcisional device100. The proximal portion of theexcisional device100 may extend from the proximal base section of theexpandable sheath495. This allows the push or turn knob226 (aturn knob226 shown inFIG. 14) to be manually accessible to the surgeon. A number of peripheral devices may be connected to theassembly600. Examples of such include acore power source480, which may be, for example, an electrical source for an ultrasound transducer, one or more data processing anddisplay devices250 on which the internal structure of the tissue imaged by theactive element440 of thecore400 may be displayed, suction means490, a cutting tool power source (a variable RF energy source, for example), and/or other devices590. Thesuction device490 may provide a suction force to thewindow120 through an internal lumen to facilitate cutting of the tissue by thecutting tool125.
• Theexcisional device assembly600 may be rotated in toto, or theexcisional device100 may be rotated independently of theexpandable sheath495, depending upon the degree of friction between the two. Preferably, theexcisional device100 is removable from the expandedsheath495 shown inFIG. 14, while leaving the expandedsheath495 in place within the soft tissue. In this manner, after retraction of theexcisional device100 from thesheath495, thesheath495 remains in place within the soft tissue to allow other instruments to be inserted therethrough. For example, theremovable core400 may, after the excisional procedure proper, be re-inserted through the expandedsheath495 to the excision site. Thereafter, the surgeon may cause theactive element440 of theremovable core400 to become energized, to image the excision site to insure that the complete lesion has been removed from the soft tissue mass. To do this, the surgeon may rotate theremovable core400 within the expandedsheath495 while observing the display or displays for signs of the lesion. If none is found, it is probable that the entire lesion has been successfully removed and the surgeon may then retract the core400 from thesheath495 and the sheath from the tissue mass and repair the incision made prior to inserting the assembly therein. Alternatively, the surgeon may choose to remove both the expandedsheath495 and thecore400 simultaneously.
• FIG. 17 shows an embodiment of the method of excisional biopsy method according to the present invention. InFIG. 17, it is assumed that the soft tissue from which the lesion is to be excised is breast tissue and that theactive element440 of theremovable core400 is an ultrasound transducer. Other combinations are possible, and the present invention should not be limited to applications related to breast tissue and ultrasound. Theremovable core400 and theactive element440, inFIG. 17, are together abbreviated as “US CORE”, a shorthand expression for the phrase “ultrasound core” and the word “assembly” is abbreviated to “Ass'y”. Moreover, it is to be understood that the steps shown inFIG. 17 constitute but a broad outline of one possible embodiment of the present inventive method. Therefore, other additional steps may be inserted between the steps shown inFIG. 17, or other steps may be substituted for some of the displayed steps without, however, departing from the scope of the present invention.
• The method starts at step S0. In step S1, the lesion within the breast is grossly targeted, using, for example, standard or stereotactic surface ultrasound. In step S1, a rough estimate of the location of the lesion within the breast is obtained. The surgeon, after having located the general location of the lesion, may mark the location thereof on the ultrasound display or displays and/or on the corresponding surface of the breast, with an “X”, for example. The breast is stabilized in step S2. Preferably, the breast is stabilized in an uncompressed or slightly expanded state, in the manner disclosed in the commonly assigned and co-pending U.S. patent application Ser. No. 09/158,215 or 09/200,661 previously discussed and incorporated by reference herein. The woman's other breast is preferably placed within a counterpart breast stabilizing device, which helps to immobilize the woman during the procedure. One of the ultrasound ports of the breast stabilizing device is aligned with the lesion, for example, by aligning one of its ultrasound ports with the marked location on the breast. Suction is then applied to the breast stabilizing device, in the manner described in the above-referenced application and a correctly oriented surface ultrasound device is secured to the ultrasound port of the stabilizing device. Other means of stabilizing the breast may also be used without, however, departing form the present invention.
• In step S3, an entry site on the breast is chosen. Preferably, the peri-areolar region is chosen as the incision site, as scars within the peri-areolar region are less visible than scars in more exposed regions of the breast and for other anatomical reasons. The incision site is then anaesthetized, both on the skin surface and subcutaneously. Also in step S3, a small incision is made at the chosen incision site. Preferably, the incision is large enough to accommodate theexpandable sheath495 with theremovable core400 inserted therein. In step S4, theexpandable sheath495, together with the removable core inserted therethrough, is inserted into the incision made in step S3. Under surface ultrasound guidance, for example, thesheath495/core400 assembly is navigated adjacent to the lesion. If thesheath495/core400 assembly can be properly positioned adjacent to the target lesion, the method according to the present invention proceeds to step S5. If thesheath495/core400 assembly cannot be properly positioned adjacent to the target lesion, all or a portion of the above-detailed steps are repeated until proper positioning of thesheath495/core400 assembly is achieved, adjacent to the target lesion.
• Assuming now that step S4 has been completed to the surgeon's satisfaction, thecore400 is removed from theexpandable sheath495 and theexpandable sheath495 is left in place within the breast, as shown in step S5. In step S6, theremovable core400 is inserted within theinternal lumen420 of the tubular member of theexcisional device100 and locked securely in place, so that the active element440 (in this case, an ultrasound transducer) is aligned with and faces out of thetransducer window410 of thedevice100. Again leaving theexpandable sheath495 in place within the breast, the excisional device100 (with thecore400 secured therein) is advanced through theexpandable sheath495. Thesheath495 then expands within the breast tissue to accommodate the somewhat larger diameter of theexcisional device100. Theexcisional device100 is advanced past the tapereddistal end520 of thesheath495, so the assembly including thesheath495, theexcisional device100 and theremovable core400 is positioned adjacent to the target lesion within the breast tissue, as shown in step S7.
• In step S8, the correct position adjacent the target lesion and the correct rotational orientation of the aforementioned assembly (FIG. 14) are confirmed, using surface ultrasound and/or thecore ultrasound400. Theactive element440 of thecore400 is particularly well suited for this task, as theexcisional device100 may be rotated within the tissue, and positioned so thecutting tool125 is properly positioned to allow it to rotate, extend and bow outwardly in such a manner as to precisely sever the lesion from the surrounding tissue with an adequate margin of healthy tissue. Indeed, theultrasound transducer440, as it rotates along with theexcisional device100, images the lesion before thecutting tool125 cuts it, thereby allowing the surgeon to optimally deploy the cutting tool based upon his or her observation of the imaged tissue on a display or displays. Instep9, the surgeon may activate an anaesthetic infusion, the anaesthetic being delivered by thecutting tool125 via the plurality of throughholes126, best seen inFIGS. 4 and 6. Step S9 may be skipped if thecutting tool125 does not provide for throughholes126 or if the surgeon does not deem it necessary to anaesthetize the tissue during the rotation of thecutting tool125. For example, the tissue may have been previously anaesthetized. While rotating at least the excisional device100 (with theremovable core400 secured therein), thecutting tool125 is extended using, for example the push or turnknob226 shown inFIGS. 2C and 14, thereby causing thecutting tool125 to extend from thewindow410 and to bow outwardly, as shown in step S10. Depending on the amount of friction between theexcisional device100 and the expandable sheath495 (which may be freely chosen depending upon the choice of material for themeshwork500 and the configuration of the mesh), thesheath495 may rotated along with theexcisional device100. The degree of extension and bowing may be finely controlled by the surgeon as theexcisional device100 is rotated, either manually or by a motorized unit (not shown) coupled thereto. As the cutting tool is rotated, the severed tissue sample is preferably collected (e.g., bagged) in a tissue collection device260 (FIGS. 2A and 2B), as shown at step S111. The blood vessels may be coagulated as the cutting tools rotates and cuts the tissue, or afterwards. In step S12, after theexcisional device100 has completed at least one revolution within the breast and has cut a volume of revolution therein, including at least the target lesion and preferably a margin of healthy tissue surrounding the lesion, theexcisional biopsy device100 andremovable core400 assembly are retracted through thesheath495, leaving thesheath495 once again in place within the breast. Preferably, thetissue collection device260 and the tissue sample it encloses lie within the recessedsection131 of the generallytubular member110. In this manner, the filledcollection device260 does not protrude or protrude too much from the surface of thetubular member110, thereby allowing the retrieved tissue sample to be readily retracted with theexcisional device100 through thesheath495.
• After retraction of theexcisional device100, thecore400 may be retracted from thedevice100 and re-inserted through thesheath495 left in place within the breast. Thecore400 is then advanced adjacent to the excision site, and rotated to allow the surgeon to image the excision site to insure that the entire lesion has indeed been removed, as shown in step S13. Some or all of the above steps may be repeated should the imaging of the excision site by thecore400 within thesheath495 reveal that a portion of the target lesion was not excised. Assuming that the entire target lesion has been removed, the incision is repaired by, for example, suturing the peri-areolar incision site. The method ends at step S16.
• Theremovable transducer core400 ofFIG. 11 is not the only removable probe that may be fitted to and within thetubular member110 of the excisional device100 (seeFIG. 10, for example). Indeed,FIG. 18 shows a top view of aremovable cutting probe700, according to an embodiment of the present invention. Theremovable probe700 includes aproximal portion702 and adistal portion704. Theproximal portion702 may include cutting tool extending means718 and thedistal portion704 may include acutting tool706, such as a wire or ribbon cutting tools described above. Thecutting tool706 may be sharpened on its leading edge. The firstremovable probe700 is preferably configured to fit at least partially within thetubular member110 to enable thecutting tool706 to selectively bow out of and to retract within afirst window710 when the cutting tool extending means718 are activated. Thefirst window710 is defined within the surface of theremovable probe700. According to an embodiment of the present invention, theremovable cutting probe700 may be inserted within the internal lumen420 (or guided within guides internal to the tubular member110) of thetubular member110 in such a manner that thewindow710 defined within theprobe700 faces the window410 (FIG. 10) defined within the surface of thetubular member110. Alternatively, thetubular member110 may define one or more additional windows similar to that shown at410 inFIG. 10. In this case, the removable probe700 (and those to be described relative toFIGS. 21-27C) may be inserted within thetubular member110 such that thewindow710 faces one of these additional windows (hereinafter collectively referenced by numeral410) and/or thewindow410 inFIGS. 10 and 12.
• According to an embodiment of the present invention, thecutting tool706 may include an RF cutting tool. In this case, the RF cutting tool and theremovable cutting probe700 may be connected to an RF power source, such as shown at240 inFIGS. 2C, 14 and18. The RF cutting tool, for example, may be either a monopolar or a bipolar RF cutting tool, as disclosed above.
• Theremovable cutting probe700 may also include an internal guide712 (or may define an internal lumen) to enable thecutting tool706 to slide within theremovable cutting probe700 when cutting tool extending means718 are activated. The cutting tools extending means718 are shown as a thumb-activated dial inFIGS. 18-20. However, any other means of advancing and retracting thecutting tool706 may also advantageously be used within the context of the present invention. According to a still further embodiment, thedistal portion704 of theremovable cutting probe700 may further include awindow slide708 disposed within thewindow710 and theproximal end702 may further include windowslide extending means716. Thewindow slide708 is coupled to the windowslide extending means716 and is guided within theremovable cutting probe700 by an internal guide orlumen714 along the length of theprobe700. According to the present invention, thewindow slide708 is configured to selectively cover a portion of thewindow710 when the windowslide extending means716 are activated. The windowslide extending means716 are shown inFIGS. 18-20 as thumb-activated dials. However, any means of extending thewindow slide708 within thewindow710 to selectively cover a portion thereof may readily be implemented within theremovable cutting probe700, as those of skill will recognize. Functionally, thewindow slide708 covers a portion of thewindow710 to selectively vary the width of thewindow710 through which thecutting tool706 is allowed to extend or bow.
• The operation of theremovable cutting probe700 is graphically shown inFIGS. 19 and 20.FIG. 19 is a side view of the removable cutting probe ofFIG. 18, showing theadjustable window slide708 in a first position, according to an embodiment of the present invention, whereasFIG. 20 is a side view of the removable cutting probe ofFIG. 18, showing theadjustable window slide708 in a second position. As shown inFIG. 19, thewindow slide708 is less engaged within thewindow710 and it is inFIG. 20. Consequently, thecutting tool706 inFIG. 19 is able to extend over a wider portion of thewindow710 than it is able to when thewindow slide708 is in the relatively more engaged position shown inFIG. 20. For example, thewindow slide708 may be further engaged within the window710 (FIG. 20) when the physician wants to cut a smaller tissue specimen than would otherwise be cut when theprobe700 is in the configuration illustrated inFIG. 19.
• FIG. 21 is a top view of a removabletissue collection probe800, according to an embodiment of the present invention. As shown therein, the removabletissue collection probe800 includes aproximal section802 and adistal section804. Theproximal section802 may include a tissue collection device extending means814 and thedistal section804 may include atissue collection device808,810. Similar to theremovable cutting probe700 ofFIGS. 18-20, the removabletissue collection probe800 may be configured to fit at least partially within thetubular member110 to enable thetissue collection device808,810 to extend out of and to retract within the window410 (or other window defined within the surface of the tubular member110) when the tissue collection device extending means814 are activated. Similar to the activating means716,718 ofFIGS. 18-20, the tissue collection device extending means814 may be configured as a thumb-dial or a wheel or as any other suitable means for extending thetissue collection device808,810, such as a lever, for example. As shown in the top view ofFIG. 21 and in the detail top view ofFIG. 22, thetissue collection device808,810 may include a ribbon orwire808 that may be configured to extend or bow out of and retract back within thewindow806 in theprobe800. Attached to the wire orribbon808 is a thin flexible sheet of non-porous orporous material810, such as polyethylene or polyethylene teraphthalate (PET), for example. A non-porous material is preferable to isolate the tissue specimen from the surrounding tissue. Such isolation is used to prevent possible cancer cells from seeding along the insertion track of the probe and/or theexcisional device100. A non-porousflexible material810 prevents fluid and cell leakage therefrom and insures isolation of the cut tissue specimen. The thin flexible sheet ofmaterial810 may be dispensed from aroll814 of such material, the free end of thesheet810 being attached to the ribbon orwire808. In this manner, theroll814 may dispense thematerial810 as the ribbon orwire808 is extended or bowed out of the window806 (and out of a corresponding (facing) window in the tubular member110) and completely or partially encompass or encapsulate the tissue specimen (seereference numeral1008 inFIGS. 27A-27C) as thetubular member110 and containedprobe800 are rotated within the patient's soft tissue. Alternatively, thetissue collection device808,810 may be configured as shown and described relative toFIGS. 2A and 2B, for example. When the tissue collection device extending means814 are activated, the ribbon orwire808 slides along the internal lumen or guide812 defined in theprobe800 and causes the ribbon orwire808 to bow and extend out of thewindow806 defined in theprobe800, thereby deploying theflexible material810 and encapsulating the tissue specimen. These embodiments allow the tissue specimen to be removed in one piece for best histological analysis by a pathologist.FIGS. 27A through 27C show still another tissue collection device configuration, as will be described below.
• FIG. 23 shows a side view of the removabletissue collection probe800 ofFIG. 21, showing thetissue collection device808,810 in an extended configuration. As shown therein, the tissue collection device extending means814 has been (manually, for example) activated to cause the bowing of thetissue collection device808,810 out of thewindow806 defined within thetissue collection probe800. This bowing, or extension, of the wire orribbon808 causes the thin sheet ofmaterial810 to be unrolled or otherwise deployed. As thetubular member110 of theexcisional device100 is rotated, the tissue collection probe contained therein is also rotated, in the direction shown byarrow816, for example. The tissue collection device extending means814 may be activated extended (bowed) so as to cause the ribbon orwire808 to follow substantially the same path within the tissue, as did thecutting tool706. This eases the collection process, as the ribbon orwire808 merely follows the path of the incision previously made by thecutting tool706 or125. As the excisional device is rotated, the tissue specimen (i.e., lesion) is captured within the sheet of material orbag810, whereupon it may readily be extracted from the patient for pathological examination.
• FIG. 24A is a top view of a removable cutting and tissuecollection combination probe900, according to an embodiment of the present invention, whereasFIG. 24B is a partial cross-sectional view of the removable cutting and tissuecollection combination probe900 ofFIG. 24A, taken along lines AA′. As shown inFIG. 24A, the combination cutting and tissue collectionremovable probe900 includes aproximal end902 and adistal end904. In the embodiment ofFIG. 24A, theproximal end902 may include cutting tool extending means908 and tissue collectiondevice extending means906. The extending means906,908 may be configured as thumb dials or as any devices that are operative to extend thetissue collection device918 and/or thecutting tool914, such as a lever, for example. As shown inFIG. 24B, the wires and/or ribbons that constitute thecutting tool914 and part of thetissue collection device918 extend from the extending means906,908 along the length of theprobe900. Thecutting tool914 and the wire or ribbon of thetissue collection device918 may be guided within theprobe900 byguides912 and910, respectively. Alternatively, thecutting tool914 and the wire or ribbon of thetissue collection device918 may be guided within theprobe900 by one or more internal lumens defined therein, in a manner similar as described relative tointernal lumen420 oftubular member110, shown inFIG. 10. As thecutting tool914 may be energized by RF energy, thecutting tool914 may be separated from thetissue collection device918 by an air gap920 (for example) of sufficient width to prevent arcing therebetween.
• FIG. 25 is a top view of a removable cutting and tissuecollection combination probe925, according to another embodiment of the present invention. The embodiment ofFIG. 25 differs from that shown inFIG. 24A in that thecutting tool914 is separated from thetissue collection device918 not by an air gap, but by an insulatingmaterial922, such as a flexible plastic insulator. In the case wherein thecutting tool914 includes an RF cutting device, thecutting tool914 is electrically coupled to an RF power source, such as shown at240. The configuration of theproximal end902 of the probe shown inFIG. 25 also differs from that shown inFIG. 24A, in that a single extendingmeans926 is configured to activate both thecutting tool914 and thetissue collection device918, as thecutting tool914 and thetissue collection device918 are mechanically coupled to one another. The assembly including the mechanically coupled cuttingtool914 andtissue collection device918 is coupled to the extending means926 along the length of the probe, and is guided there along by an internal guide orlumen924.
• FIG. 26 is a side view of a removable cutting and tissuecollection combination probe950, according to a still further embodiment of the present invention, wherein thecutting tool930 and thetissue collection device932,934 are shown in their extended (bowed) configurations. As shown, theprobe950 includes aproximal portion902 and adistal portion904. In the embodiment ofFIG. 26, theproximal portion902 includes a cutting tool extending means926 that is configured to activate thecutting tool930 and a tissue collection device extending means944 that is configured to activate and extend thetissue collection device932,934. Thetissue collection device932,934 may include a ribbon orwire932 that is adapted to bow (extend) out of and to retract back within afirst window942 defined within theprobe950. A thin and flexible sheet ofmaterial934 is attached to the trailing edge of the wire orribbon932 to encapsulate or otherwise capture the cut tissue specimen upon activation of thetissue collection device932,934 and rotation of thetubular member110 and probe950, in the direction indicated byarrow928, for example. Similarly, the cutting tool930 (including an RF cutting tool, for example) is configured to extend out of and retract back into asecond window936. Both of the first andsecond windows942,936, when theprobe950 is inserted into thetubular member110, are aligned with corresponding windows defined within thetubular member110. One such window is shown inFIG. 10 atreference numeral410.
• Thecombination probe950 ofFIG. 26 may also include a plurality of through holes in fluid communication with aninternal lumen940 defined within the internal wall of theprobe950. In turn, theinternal lumen940 is in fluid communication with aport942, which may be disposed at the proximal end of theprobe950. The throughholes938 may be utilized for the delivery of a fluid to the patient during the excisional procedure, such as antibiotic agents, analgesic agents or most any pharmaceutical agent. Such agents may be administered to the patient from theport942. Alternatively, theport942 may be coupled to suction and the throughholes938 may be utilized to suction out the excisional site of smoke, blood or other bodily fluids during or after the excisional procedure. Alternatively still, more than oneport942 may be provided in theproximal portion902 and more than onelumen940 may be defined along the length of theprobe950. The additional lumen may be in fluid communication with selected throughholes938. By this structure, both delivery of a pharmaceutical agent and suctioning may be provided within asingle probe950.
• Although the probes shown inFIGS. 18-26 have been described as removable probes adapted to fit at least partially within theexcisional device110, it should be noted that they need not be utilized therewith, and may be utilized independently thereof. For example, the cutting probe ofFIGS. 18-20 may be inserted and operated within soft tissue by themselves, without being inserted in theexcisional device110 ofFIG. 10. Likewise, thetissue collection probe800 may be utilized without theexcisional device110. For example, the cuttingprobe700 ofFIGS. 18-20 may be utilized to cut the tissue specimen from the surrounding soft tissue, whereupon thetissue collection probe800 ofFIGS. 21-23 may be inserted after removal of thecutting probe700. Moreover, the features of each of the probes ofFIGS. 18-27C may be combined to best suit the application envisaged. The present invention, therefore, is not to be limited by the specific embodiments illustrated inFIGS. 18-27C, as various other combinations of the disclosed features are possible, as those of skill will readily recognize.
• FIG. 27A-27C are partial cross-sections of atissue collection probe1000, taken at the level of thetissue collection device1018 thereof, as theprobe1000 captures and encapsulates a tissue specimen (lesion)1008 within the patient's soft tissue, such as the breast. Turning first toFIG. 27A, thetissue collection device1018 includes a thin sheet offlexible material1002, which is folded on itself. One end of the thin flexible sheet ofmaterial1002 is coupled at1006 to theribbon1004, while the other end thereof is attached to the body of theprobe1000. Theribbon1004 is configured to selectively extend out of and retract back into a window, such as shown at806 inFIG. 23, for example. A tissue specimen (lesion)1008 is to be excised from thesoft tissue1018. To do so, the excisional device110 (and thus theprobe1000 fitted therein) is rotated in the direction of thearrow1010, while theribbon1004 is extended (bowed) in the direction ofarrow1012, shown inFIG. 27B. As theribbon1004 is extended, it unfolds and deploys the thin sheet offlexible material1002, to at least partially encapsulate thetissue specimen1008. As shown inFIG. 27C, theribbon1004 of thetissue collection device1018 may then be retracted in the direction ofarrow1016 after the rotation1014 (FIG. 27B) of theexcisional device110 causes thetissue specimen1008 to be fully encompassed or encapsulated by the thin sheet offlexible material1002. Theexcisional device110 may then be removed from the patient, along with the collectedtissue specimen1008. To aid in the visualization of thetissue collection device1018 during the excisional procedure, theribbon1004 thereof may include or be coated with a radiopaque material or may include a material readily visible by surface or intra-tissue ultrasound.
• FIG. 28 is a flowchart of a soft tissue treatment method, according to another embodiment of the present invention. As shown in step S281, the cutting probe, such as shown at700 inFIGS. 18-20, is inserted into theexcisional device100. Theexcisional device100 and cuttingprobe assembly700 is then inserted into the patient's soft tissue, at the site of interest. Thecutting tool710 of theprobe assembly700 is extended (bowed) to cut the tissue specimen of interest from the surrounding tissue and theexcisional device100 is then rotated, as shown at step S282. Step S283 calls for the removal of thecutting probe700 from theexcisional device100, leaving theexcisional device100 in place within the patient. A tissue collection probe, such as shown at800 inFIGS. 21-23, may then be inserted within the excisional device100 (if not already inserted therein), as shown at S284. The tissue collection device808-810 may be extended (bowed) out from theexcisional device100 and the assembly including theexcisional device100 andtissue collection probe800 may then be rotated (in a direction opposite from the direction of rotation during the cutting step S282, for example). As noted in step S285, this extends the collection device808-810 along the same path as traveled by thecutting tool710 of thecutting probe700 in step S282 and causes the tissue collection device808-810 to at least partially encompass (encapsulate) the tissue specimen, as shown, for example inFIG. 27C. The assembly including theexcisional device100 andtissue collection device800 and the encapsulated tissue specimen may then be retracted from the patient, as shown at S286, and the specimen forwarded for histological analysis.
• Alternatively, the combination cutting andtissue collection probe900 may be inserted in the excisional device, instead of consecutively inserted thecutting probe700 andtissue collection probe800 therein. In this case, thetissue collection device918 or932,934 may be activated simultaneously with or after the deployment of thecutting tool914. Moreover, to better control the deployment of the cutting tool ofFIGS. 18-20 or24A-26 and/or the tissue collection device ofFIGS. 21-23,24A-26 or27A-27C, an intra-tissue ultrasound sensor such as described relative toFIGS. 1-17 may be used, to sweep a plane ahead of the cutting tool and/or tissue collection device as thetubular member110 of theexcisional device100 rotates.
• While the foregoing detailed description has described several embodiments of this invention, it is to be understood that the above description is illustrative only and not limiting of the disclosed invention. For example, the method of the present invention may also be carried out without the use of thetubular member110, by inserting the probes disclosed herein relative toFIGS. 18-27C directly in the patient's soft tissue, as the present cutting and tissue collection probes have utility independent of theexcisional device100. A number of other modifications will no doubt occur to persons of skill in this art. For example, the shape and placement of the cutting device and tissue collection extending means (814,906,908,926,944) may differ from that illustrated and described herein, for ergonomical or other concerns. All such modifications, however, should be deemed to fall within the scope of the present invention. Thus, the invention is to be limited only by the claims as set forth below.

Claims (6)

1-77. (canceled)

78. A device configured to remove a specimen of breast tissue that is cut from surrounding breast tissue, comprising:

a shaft, and

a tissue collection element coupled to the shaft, the tissue collection element including a thin flexible membrane, the tissue collection device being movable from a retracted position to an expanded position, the thin flexible membrane being configured to encapsulate the cut specimen while maintaining the cut specimen intact and isolating the captured specimen from contact with the surrounding breast tissue.

79. The device ofclaim 78, wherein the tissue collection element includes a flexible element to which the thin flexible membrane is attached and wherein the flexible element is configured to selectively bow away from and retract toward the shaft.

80. The device ofclaim 78, wherein the thin flexible membrane forms a bag.

81. The device ofclaim 80, wherein the bag is configured to selectively open to capture the cut specimen and close to encapsulate the cut specimen as the tissue collection element bows away from and retracts toward the shaft, respectively.

82. The device ofclaim 78, wherein the tissue collection element is configured to expand to a size at least equal to the size of the cut specimen.

Images